Randox at MEDLAB Middle East 2017 - Stand No. Z5.B10

Location : Dubai International Convention & Exhibition Centre
  Date : 5th - 8th of February 2018


  • Reagents
  • Cardiac Risk

Randox reagents are internationally recognised as being of the highest quality, offering reliable and rapid diagnosis. Our product portfolio offers more than 100 clinical assays, covering testing panels such as routine chemistry, lipids and cardiology, diabetes, therapeutic drugs monitoring, drugs of abuse testing, antioxidants and veterinary. Randox strive to continuously improve diagnostic solutions- this has led to the development of a range of high performance, speciality reagents.

Some examples of these assays include:


Bilirubin-Vanadate Oxidation

Elevated bilirubin concentrations can lead to the development of jaundice, a side effect of toxic or infectious liver diseases such as hepatitis B or obstruction of the bile duct. Bilirubin levels are also important during the process of diagnosing and monitoring liver diseases including hepatitis, cirrhosis and gallstones.

  • Superior Vanadate Oxidation methodology – Unlike diazo-based methods, the vanadate oxidation method does not suffer from interference from non-conjugated bilirubin
  • Limited interference – from haemoglobin and lipids
  • Liquid ready-to-use reagents
  • No pre-step required– other commercially available assays may involve a pre-step, however with the Randox Vanadate Oxidation method this step is eliminated, helping enhance testing efficiency
  • Applications available – with instrument-specific setting for a wide range of biochemistry analysers



Fructosamine is a mid-term indicator of diabetic control as it can provide information on a person’s average blood glucose levels over the preceding 14-21 days.
Due to the shorter time span of fructosamine, it is often used to evaluate the effectiveness of medication changes and to monitor the treatment of gestational diabetes. Fructosamine is also particularly useful in situations where HbA1c cannot be reliably measured e.g. haemolytic anaemia, thalassemia or with genetic haemoglobin variants.

  • High performance method – the Randox Fructosamine assay employs an enzymatic method which offers improved specificity and reliability compared to conventional NBT-based methods. The Randox enzymatic method does not suffer from non-specific interferences unlike other commercially available fructosamine assays
  • Liquid ready-to-use reagents– for ease of use and convenience
  • Limited interference – from Bilirubin, Glucose, Haemoglobin, Intralipid® and Triglycerides ensuring truly accurate results are produced
  • Applications available – with instrument specific settings for a wide range of analysers
  • Fructosamine controls and fructosamine calibrator available


Cystatin C

Randox Cystatin C offers an alternative to traditional creatinine testing. Randox Cystatin C is extremely sensitive to small changes in Glomerular Filtration Rate (GFR) and is therefore able to detect early reductions in this rate. Furthermore, it is unaffected by non-renal factors such as gender, age and weight. Creatinine testing cannot offer these advantages.

  • Liquid ready-to-use reagents
  • Extensive measuring range– 0.4-10mg/l, allowing normal and abnormal samples to be accurately measured without additional dilutions
  • 7 day calibration frequency-advantageous when running Cystatin C as part of routine testing
  • Applications available – with instrument-specific setting for a wide range of biochemistry analysers



Non-Esterified Fatty Acids (NEFA) are molecules released from triglycerides by the action of the enzyme lipase and are transported in the blood bound to albumin.
Measurement of NEFA is particularly important in diabetes where insulin deficiency results in the metabolism of fat. Levels are also frequently increased in obese patients.
• Lypohilised reagents – for enhanced stability
 Calibrator supplied with kit –simplifying the ordering process
• Excellent measuring range – of 0.072 to 2.24 mmol/l for comfortable detection of abnormal levels
 Applications available – with instrument-specific setting for a wide range of biochemistry analysers
 Colorimetric method
• Complementary controls and calibrators available

Randox are at the forefront of developing high quality diagnostic solutions for the cardiology field. We are revolutionising the early detection of cardiovascular disease through our innovations that make a real difference to both the clinician and the patient.



HDL2/3-C is a subfraction of the HDL particle. Elevated levels of HDL2/3-C reflect increased triglyceride content of the HDL particle. Randox are proud to present a new automated biochemistry assay for the measurement of HDL2/3-C.
Key Features of Randox HDL2/3-C:

  • Liquid ready-to-use
  • Available on most automated biochemistry analysers
  • A 2 step procedure based on patented technology from Denka Seiken
  • Open vial stability of 28 daysat +2 to +8°C
  • Dedicated calibrator available
  • Measuring range of 4 – 60mg/dl
  • Demonstrates a strong correlation with the conventional Ultracentrifugation method
  • Allows for quantification of HDL2-C by the subtraction of HDL3-C from total HDL-C
  • Measures total HDL2/3-C.


sLDL Cholesterol

Research has indicated that individuals with a predominance of sLDL have a three-fold increased risk of suffering from a heart attack, making sLDL measurement extremely valuable. To date, ultracentrifugation and electrophoresis-based methods have been used for the measurement of sLDL but these methods are both laborious and time-consuming. Randox offers a superior alternative for sLDL testing- a direct, more efficient method which is designed for use on automated chemistry analysers.

  • Direct, automated methodology – the Randox sLDL assay is designed for use on automated analysers making the test more convenient and efficient. Traditional ultracentrifugation and electrophoresis-based methods can take up to eight hours to complete just ten tests, monopolising laboratory time
  • Rapid analysis – results can be produced in as little as ten minutes, facilitating faster patient diagnosis and the implementation of treatment
  • Applications available – with instrument specific settings for a wide range of analysers.



Raised levels of homocysteine can be associated with various disease states including cardiovascular disease, diabetes, dementia, osteoporosis and complications during pregnancy, making homocysteine an essential addition to a laboratory’s testing panel.

  • 2-part liquid ready-to-use kitwith calibrators included
  • Minimal interference –ensuring accurate and precise results are produced every time
  • Excellent measuring range – 1.74-47.9µmol/l, enabling the Randox assay to detect abnormal levels related to all homocysteine associated disease states.



Elevated levels of Lipoprotein(a) (Lp(a)) are considered to be both a causal risk factor and independent genetic marker of atherosclerotic disorders. The major challenge with this test is the size variation of apo(a) within Lp(a). Dependent upon the size of apo(a) in the assay calibrator, many assays under or overestimate apo(a) size in the patient sample. The antibody used in the Randox method detects the complete Lp(a) molecule providing the most accurate and consistent results.

  • Liquid ready-to-use reagents
  • Superior methodology – displaying minimal Apo(a) size related bias
  • Five point calibrator available – giving a true reflection of the isoforms present in the population